The University of Hong Kong team is aiming to test the hepatitis B drug in the region. Photo: Shutterstock
The University of Hong Kong team is aiming to test the hepatitis B drug in the region. Photo: Shutterstock

Hong Kong researchers offer some hepatitis B patients hope with new drug that suppresses virus long term

  • Drug helps one in 10 patients achieve ‘functional cure’ and they can stop taking medicine for life
  • HKU team hopes to achieve 30 per cent success rate in next stage of drug trials to be done in the region

The University of Hong Kong team is aiming to test the hepatitis B drug in the region. Photo: Shutterstock
The University of Hong Kong team is aiming to test the hepatitis B drug in the region. Photo: Shutterstock
READ FULL ARTICLE